RE:RE:RE:RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock OptionsPersonally, I do not trust current leadership, as they have consistently over stated and under performed. Management states they are entitled to 10% equity in this company on a yearly basis, IMO they are hugely over stating their personal worth. The 10% Equity Incentive Plan needs to be fully explained to share holders before the mext AGM. The next AGM must be zoomed and shareholders should, IMO be ready to replace leadership with a member / members of the SAB.
We are expecting a 5 or 6 product line release 2nd quarter, which we are in now and yet not a word has been mentioned on any platform. For a company keen on hype, very little in this instance. Minimal interest in our company, proven by the slow share price deterioration since beginning of 2024. IMO, time for a change.